Accuray (ARAY) Capital Expenditures Growth (3y) (2013 - 2026)
Accuray (ARAY) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.81% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.84% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 2.15% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 7.57% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Accuray | 29,832.96 | -38.50 Mn | 25.29 Mn | 65.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.45% |
| Dec 31, 2025 | 87.28% |
| Sep 30, 2025 | -23.88% |
| Mar 31, 2025 | -3.85% |
| Dec 31, 2024 | -62.90% |
| Sep 30, 2024 | -32.89% |
| Mar 31, 2024 | -50.41% |
| Dec 31, 2023 | -51.42% |
| Sep 30, 2023 | 24.27% |
| Mar 31, 2023 | -23.36% |
| Dec 31, 2022 | -40.19% |
| Sep 30, 2022 | 0.13% |
| Mar 31, 2022 | 48.31% |
| Dec 31, 2021 | 9.24% |
| Sep 30, 2021 | -3.14% |
| Mar 31, 2021 | -18.34% |
| Dec 31, 2020 | -17.06% |
| Sep 30, 2020 | -15.08% |
| Jun 30, 2020 | 30.70% |
| Mar 31, 2020 | -21.80% |